Efficacy of Breast Cancer Surveillance in Japanese BRCA1/2 Mutation Carriers

Efficacy of Breast Cancer Surveillance in Japanese BRCA1/2 Mutation Carriers - Breast Cancer Surveillance in Japanese BRCA1/2 Mutation Carriers

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026509

Enrollment

100

Registered

2017-03-13

Start date

2016-12-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BRCA1/2 Mutation Carriers

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: BRCA1/2 mutation carriers

Exclusion criteria

Exclusion criteria: The individuals who do not wish to participate to this study.

Design outcomes

Primary

Measure	Time frame
We investigated the distinct roles of mammography, ultrasonography, MRI, and CBE for the detection of breast cancer in women with BRCA1/2 mutations. The medical records of participants who were confirmed to have BRCA1/2 mutations during genetic counseling between January 1, 2000 and October 31, 2016 were reviewed.	—

Countries

Japan

Contacts

Public ContactMasami Arai, Satoko Shimada

Cancer Institute Hospital clinical genetic oncology

marai@jfcr.or.jp03-3520-0111

Outcome results